{"id":129911,"date":"2021-08-18T13:00:00","date_gmt":"2021-08-18T13:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2902705"},"modified":"2021-08-18T13:00:00","modified_gmt":"2021-08-18T13:00:00","slug":"the-biopharmaceutical-contract-manufacturing-by-roots-analysis","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/","title":{"rendered":"The biopharmaceutical contract manufacturing by Roots Analysis"},"content":{"rendered":"<p><img decoding=\"async\" width=\"273\" height=\"260\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><em>Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise \/ larger production capacities of CMOs \/ CDMOs and achieve significant cost and time related advantages<\/em><\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/\"><strong>Roots Analysis<\/strong><\/a>&nbsp;is pleased to announce the publication of its recent study, titled, &nbsp;&ldquo;<a href=\"https:\/\/rootsanalysis.com\/reports\/view_document\/biopharma-contract-manufacturing-market-3rd-edition-2019-2030\/250.html\"><strong>Biopharma Contract Manufacturing Market (3<sup>rd<\/sup>&nbsp;Edition), 2019-2030<\/strong><\/a><strong>.<\/strong>&rdquo;&nbsp;<\/p>\n<p>The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs. Amongst other elements, the report includes:<\/p>\n<p>A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters.<\/p>\n<p>Elaborate profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biologics.<\/p>\n<ul>\n<li>A detailed discussion on the key enablers in this domain, including certain niche product classes, which are likely to have a significant impact on the growth of the contract services market.<\/li>\n<li>A case study on the growing global biosimilars market, highlighting the opportunities for biopharmaceutical CMOs and CDMOs.<\/li>\n<li>A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.<\/li>\n<li>A discussion on challenges related to in-house manufacturing, featuring a brief overview of the various parameters that a drug \/ therapy developer may need to take into consideration while deciding whether to manufacture its products in-house or outsource.<\/li>\n<\/ul>\n<p>An analysis of the recent collaborations (signed since 2013) focused on the contract manufacturing of biologics.<\/p>\n<p>A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2013-2018, along with the geographical distribution of this activity.<\/p>\n<p>An in-depth analysis of more than 490 grants that have been awarded to research institutes engaged in next generation immune checkpoint therapy-related projects.<\/p>\n<p>An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions.<\/p>\n<p>A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.<\/p>\n<p>A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.<\/p>\n<p>A discussion on affiliated trends, key drivers, and challenges, under a comprehensive SWOT framework.<\/p>\n<ul>\n<li>A survey analysis featuring inputs solicited from various experts who are directly \/ indirectly involved in providing CMO services to medical device developers.<\/li>\n<li>A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)<\/li>\n<\/ul>\n<p>Commonly Outsourced Business Operations<\/p>\n<p>Active Pharmaceutical Ingredients (API)<\/p>\n<p>Finished Dosage Formulations (FDF)<\/p>\n<p>Types of Expression System<\/p>\n<p>Mammalian<\/p>\n<p>Microbial<\/p>\n<p>Others<\/p>\n<p>Company Size<\/p>\n<p>Small<\/p>\n<p>Mid-Sized<\/p>\n<p>Large and Very Large<\/p>\n<p>Scale of Operation<\/p>\n<p>Preclinical<\/p>\n<p>Clinical<\/p>\n<p>Commercial<\/p>\n<p>Key Geographical Region<\/p>\n<p>North America<\/p>\n<p>Europe<\/p>\n<p>Asia-Pacific<\/p>\n<p>Rest of the World<\/p>\n<p>Report link &#8211;&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/biopharmaceutical-contract-manufacturing-market\/250.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/biopharmaceutical-contract-manufacturing-market\/250.html<\/a><\/p>\n<p>The report also features detailed transcripts of discussions held with the following experts:<\/p>\n<ul>\n<li>Astrid Brammer, Senior Manager Business Development, Richter-Helm Mathias Schmidt (Chief Executive Officer, ArmaGen)<\/li>\n<li>Birgit Schwab, Senior Manager Strategic Marketing, Rentschler Biotechnologie<\/li>\n<li>Christian Bailly, Director of CDMO, Pierre Fabre<\/li>\n<li>Claire Otjes, Assistant Marketing Manager, Batavia Biosciences<\/li>\n<li>David C Cunningham, Director Corporate Development, Goodwin Biotechnology<\/li>\n<li>Dietmar Katinger, Chief Executive Officer, Polymun Scientific<\/li>\n<li>Denis Angioletti, Chief Commercial Officer, Cerbios-Pharma<\/li>\n<li>Jeffrey Hung, Chief Commercial Officer, Vigene Biosciences<\/li>\n<li>Kevin Daley, Director Pharmaceuticals, Novasep<\/li>\n<li>Mark Wright, Site Head, Grangemouth, Piramal Healthcare<\/li>\n<li>Nicolas Grandchamp, R&amp;D Leader, GEG Tech<\/li>\n<li>Raquel Fortunato, Chief Executive Officer, GenIbet Biopharmaceuticals<\/li>\n<li>Sebastian Schuck, Head of Business Development, Wacker Biotech<\/li>\n<li>Stephen Taylor, Senior Vice President Commercial, FUJIFILM Diosynth Biotechnologies<\/li>\n<li>Tatjana Buchholz, Marketing Manager, PlasmidFactory and Marco Schmeer, Project Manager, PlasmidFactory<\/li>\n<li>Tim Oldham, Chief Executive Officer, Cell Therapies<\/li>\n<\/ul>\n<p>Key companies covered in the &#8211;&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/250\/request-sample.html\">https:\/\/www.rootsanalysis.com\/reports\/250\/request-sample.html<\/a><\/p>\n<p>3P Biopharmaceuticals<\/p>\n<p>Abzena<\/p>\n<p>Albany Molecular Research<\/p>\n<p>BioVectra<\/p>\n<p>BioXcellence (Boehringer Ingelheim)<\/p>\n<p>Celonic<\/p>\n<p>Charles River Laboratories<\/p>\n<p>ChemPartner<\/p>\n<p>Cobra Biologics<\/p>\n<p>CordenPharma<\/p>\n<p>Cytovance Biologics<\/p>\n<p>GE Healthcare<\/p>\n<p>Goodwin Biotechnology<\/p>\n<p>Grand River Aseptic Manufacturing<\/p>\n<p>IDT Biologika<\/p>\n<p>KBI BioPharma<\/p>\n<p>Kemwell Biopharma<\/p>\n<p>LFB Biomanufacturing<\/p>\n<p>Meridian Life Science<\/p>\n<p>Patheon<\/p>\n<p>Pfizer CentreOne<\/p>\n<p>PX&#8217;Therapeutics<\/p>\n<p>Samsung BioLogics<\/p>\n<p>Sanofi, CEPiA<\/p>\n<p>Thermo Fisher Scientific<\/p>\n<p>Vetter Pharma International<\/p>\n<p>For more information please click on the following link:<\/p>\n<p><a href=\"https:\/\/rootsanalysis.com\/reports\/view_document\/biopharma-contract-manufacturing-market-3rd-edition-2019-2030\/250.html\"><strong>Biopharma Contract Manufacturing Market (3<sup>rd<\/sup>&nbsp;Edition), 2019-2030<\/strong><\/a><\/p>\n<p><strong>Other Recent Offerings<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapy-manufacturing\/285.html\">Cell Therapy Manufacturing<\/a>&nbsp;Market (3<sup>rd<\/sup>&nbsp;Edition), 2019-2030<\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/antibody-cmo-market\/295.html\">Antibody Contract Manufacturing<\/a>&nbsp;Market, 2020-2030<\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/313.html\">China Biopharmaceutical Contract Manufacturing<\/a>&nbsp;Market, 2020-2030<\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/peptide-therapeutics-manufacturing\/305.html\">Peptide Therapeutics<\/a>: Contract API Manufacturing Market, 2020-2030<\/li>\n<\/ul>\n<p><a name=\"_Hlk80171982\"><\/a><strong>About Roots Analysis<\/strong><\/p>\n<p>Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you&rsquo;d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/rootsanalysis\/\" rel=\"tag\">Rootsanalysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/contract\/\" rel=\"tag\">Contract<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/biopharmaceutical\/\" rel=\"tag\">Biopharmaceutical<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/research\/\" rel=\"tag\">Research<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/manufacturing\/\" rel=\"tag\">manufacturing<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/biopharmaceutical-contract-manufacturing-cmo-mar\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/biopharmaceutical-contract-manufacturing-cmo-mar<\/a><br \/><b>Contact Information:<\/b><br \/>Gaurav Chaudhary gaurav.chaudhary@rootsanalysis.com Roots Analysis A430, 4th Floor, Bestech Business Towers, Sector 66, Mohali, India sales@rootsanalysis.com +1 (415) 800 3415 +44 (122) 391 1091 Web: https:\/\/www.rootsanalysis.com\/ LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis Twitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/pr-wirein\/\" rel=\"category tag\">PR-Wirein<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/wire\/\" rel=\"category tag\">Wire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Gaurav Chaudhary<br \/> gaurav.chaudhary@rootsanalysis.com<br \/> Roots Analysis<br \/> A430, 4th Floor,<br \/> Bestech Business Towers, Sector 66, Mohali, India<br \/> sales@rootsanalysis.com<br \/> +1 (415) 800 3415<br \/> +44 (122) 391 1091<br \/> Web: https:\/\/www.rootsanalysis.com\/<br \/> LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/> Twitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\">The biopharmaceutical contract manufacturing by Roots Analysis<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise \/ larger production capacities of CMOs \/ CDMOs and achieve significant cost and time related advantages Roots Analysis&nbsp;is pleased to announce the publication of its recent study, titled, &nbsp;&ldquo;Biopharma Contract Manufacturing Market (3rd&nbsp;Edition), 2019-2030.&rdquo;&nbsp; The report features an extensive study [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\">The biopharmaceutical contract manufacturing by Roots Analysis<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-129911","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The biopharmaceutical contract manufacturing by Roots Analysis - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The biopharmaceutical contract manufacturing by Roots Analysis - Business\" \/>\n<meta property=\"og:description\" content=\"Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise \/ larger production capacities of CMOs \/ CDMOs and achieve significant cost and time related advantages Roots Analysis&nbsp;is pleased to announce the publication of its recent study, titled, &nbsp;&ldquo;Biopharma Contract Manufacturing Market (3rd&nbsp;Edition), 2019-2030.&rdquo;&nbsp; The report features an extensive study [&hellip;] The post The biopharmaceutical contract manufacturing by Roots Analysis appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-18T13:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\",\"name\":\"The biopharmaceutical contract manufacturing by Roots Analysis - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\",\"datePublished\":\"2021-08-18T13:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The biopharmaceutical contract manufacturing by Roots Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The biopharmaceutical contract manufacturing by Roots Analysis - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/","og_locale":"en_US","og_type":"article","og_title":"The biopharmaceutical contract manufacturing by Roots Analysis - Business","og_description":"Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise \/ larger production capacities of CMOs \/ CDMOs and achieve significant cost and time related advantages Roots Analysis&nbsp;is pleased to announce the publication of its recent study, titled, &nbsp;&ldquo;Biopharma Contract Manufacturing Market (3rd&nbsp;Edition), 2019-2030.&rdquo;&nbsp; The report features an extensive study [&hellip;] The post The biopharmaceutical contract manufacturing by Roots Analysis appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/","og_site_name":"Business","article_published_time":"2021-08-18T13:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/","url":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/","name":"The biopharmaceutical contract manufacturing by Roots Analysis - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png","datePublished":"2021-08-18T13:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/08\/18\/the-biopharmaceutical-contract-manufacturing-by-roots-analysis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"The biopharmaceutical contract manufacturing by Roots Analysis"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/129911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=129911"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/129911\/revisions"}],"predecessor-version":[{"id":129912,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/129911\/revisions\/129912"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=129911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=129911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=129911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}